Pliant Therapeutics IncNASDAQ:PLRX
- LAST PRICE14.1500
- TODAY'S CHANGE (%)0.2600 (1.8719%)
- Bid / Lots14.1500/ 3
- Ask / Lots16.2000/ 1
- Open / Previous Close13.8700 / 13.8900
- Day Range
- 52 Week Range
- Volume378,662
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | PLRX |
|---|---|---|
| 09:32 ET | 3294 | 13.8 |
| 09:33 ET | 300 | 13.78 |
| 09:35 ET | 1709 | 13.535 |
| 09:37 ET | 300 | 13.57 |
| 09:39 ET | 700 | 13.61 |
| 09:46 ET | 1565 | 13.52 |
| 09:48 ET | 433 | 13.43 |
| 09:50 ET | 400 | 13.44 |
| 09:53 ET | 2586 | 13.46 |
| 09:55 ET | 1532 | 13.47 |
| 09:57 ET | 1920 | 13.555 |
| 10:02 ET | 100 | 13.585 |
| 10:06 ET | 414 | 13.61 |
| 10:08 ET | 400 | 13.61 |
| 10:11 ET | 530 | 13.555 |
| 10:15 ET | 300 | 13.49 |
| 10:20 ET | 300 | 13.49 |
| 10:22 ET | 507 | 13.53 |
| 10:24 ET | 655 | 13.64 |
| 10:27 ET | 435 | 13.685 |
| 10:29 ET | 505 | 13.67 |
| 10:31 ET | 1744 | 13.72 |
| 10:33 ET | 400 | 13.66 |
| 10:36 ET | 300 | 13.705 |
| 10:38 ET | 900 | 13.785 |
| 10:40 ET | 2000 | 13.8194 |
| 10:42 ET | 100 | 13.74 |
| 10:44 ET | 947 | 13.77 |
| 10:45 ET | 235 | 13.75 |
| 10:51 ET | 800 | 13.74 |
| 10:54 ET | 200 | 13.725 |
| 10:58 ET | 200 | 13.7 |
| 11:00 ET | 103 | 13.7059 |
| 11:02 ET | 2200 | 13.64 |
| 11:03 ET | 3546 | 13.77 |
| 11:05 ET | 200 | 13.77 |
| 11:07 ET | 300 | 13.81 |
| 11:09 ET | 300 | 13.78 |
| 11:12 ET | 3374 | 13.91 |
| 11:14 ET | 900 | 13.83 |
| 11:16 ET | 2223 | 13.9 |
| 11:18 ET | 700 | 13.87 |
| 11:20 ET | 200 | 13.89 |
| 11:21 ET | 968 | 13.81 |
| 11:23 ET | 200 | 13.82 |
| 11:25 ET | 300 | 13.85 |
| 11:30 ET | 2500 | 13.9 |
| 11:32 ET | 1298 | 13.84 |
| 11:34 ET | 550 | 13.86 |
| 11:36 ET | 556 | 13.84 |
| 11:38 ET | 200 | 13.83 |
| 11:43 ET | 300 | 13.8571 |
| 11:45 ET | 764 | 13.85 |
| 11:48 ET | 1382 | 13.86 |
| 11:50 ET | 5199 | 13.82 |
| 11:54 ET | 1264 | 13.82 |
| 11:56 ET | 2706 | 13.91 |
| 11:57 ET | 1435 | 13.925 |
| 11:59 ET | 600 | 13.87 |
| 12:01 ET | 100 | 13.85 |
| 12:03 ET | 135 | 13.87 |
| 12:08 ET | 2700 | 13.87 |
| 12:10 ET | 100 | 13.86 |
| 12:12 ET | 1800 | 13.91 |
| 12:15 ET | 2044 | 13.87 |
| 12:17 ET | 1700 | 13.84 |
| 12:19 ET | 900 | 13.81 |
| 12:21 ET | 300 | 13.8271 |
| 12:24 ET | 1236 | 13.84 |
| 12:28 ET | 300 | 13.84 |
| 12:30 ET | 900 | 13.88 |
| 12:32 ET | 500 | 13.89 |
| 12:33 ET | 600 | 13.9 |
| 12:35 ET | 300 | 13.895 |
| 12:37 ET | 100 | 13.92 |
| 12:42 ET | 100 | 13.92 |
| 12:44 ET | 300 | 13.92 |
| 12:46 ET | 830 | 13.905 |
| 12:48 ET | 444 | 13.91 |
| 12:50 ET | 1385 | 13.87 |
| 12:51 ET | 202 | 13.875 |
| 12:53 ET | 1013 | 13.81 |
| 12:55 ET | 300 | 13.84 |
| 12:57 ET | 1734 | 13.88 |
| 01:00 ET | 220 | 13.89 |
| 01:02 ET | 732 | 13.84 |
| 01:08 ET | 901 | 13.87 |
| 01:09 ET | 772 | 13.84 |
| 01:11 ET | 200 | 13.835 |
| 01:18 ET | 2250 | 13.76 |
| 01:20 ET | 216 | 13.73 |
| 01:24 ET | 429 | 13.745 |
| 01:29 ET | 200 | 13.71 |
| 01:31 ET | 1050 | 13.65 |
| 01:36 ET | 1375 | 13.7 |
| 01:40 ET | 1800 | 13.76 |
| 01:42 ET | 1321 | 13.73 |
| 01:44 ET | 100 | 13.71 |
| 01:45 ET | 406 | 13.755 |
| 01:47 ET | 100 | 13.73 |
| 01:51 ET | 3019 | 13.78 |
| 01:54 ET | 800 | 13.79 |
| 01:56 ET | 105 | 13.79 |
| 01:58 ET | 5012 | 13.77 |
| 02:00 ET | 100 | 13.77 |
| 02:02 ET | 270 | 13.785 |
| 02:03 ET | 200 | 13.77 |
| 02:05 ET | 2458 | 13.79 |
| 02:07 ET | 500 | 13.78 |
| 02:09 ET | 682 | 13.77 |
| 02:12 ET | 225 | 13.785 |
| 02:14 ET | 616 | 13.76 |
| 02:16 ET | 1624 | 13.72 |
| 02:18 ET | 500 | 13.715 |
| 02:20 ET | 644 | 13.68 |
| 02:21 ET | 717 | 13.68 |
| 02:25 ET | 100 | 13.69 |
| 02:30 ET | 400 | 13.68 |
| 02:32 ET | 2093 | 13.65 |
| 02:34 ET | 400 | 13.66 |
| 02:36 ET | 414 | 13.66 |
| 02:38 ET | 6675 | 13.66 |
| 02:39 ET | 1443 | 13.695 |
| 02:41 ET | 494 | 13.69 |
| 02:43 ET | 1063 | 13.64 |
| 02:45 ET | 500 | 13.65 |
| 02:48 ET | 200 | 13.64 |
| 02:50 ET | 1492 | 13.64 |
| 02:52 ET | 1288 | 13.6423 |
| 02:54 ET | 500 | 13.67 |
| 02:56 ET | 541 | 13.65 |
| 02:57 ET | 2550 | 13.66 |
| 02:59 ET | 1600 | 13.67 |
| 03:03 ET | 932 | 13.69 |
| 03:06 ET | 696 | 13.695 |
| 03:08 ET | 2319 | 13.71 |
| 03:10 ET | 1157 | 13.795 |
| 03:12 ET | 831 | 13.81 |
| 03:15 ET | 100 | 13.835 |
| 03:17 ET | 1377 | 13.829 |
| 03:19 ET | 400 | 13.81 |
| 03:21 ET | 4145 | 13.84 |
| 03:26 ET | 100 | 13.9 |
| 03:28 ET | 268 | 13.9 |
| 03:30 ET | 1316 | 13.92 |
| 03:32 ET | 3932 | 13.915 |
| 03:33 ET | 342 | 13.929 |
| 03:35 ET | 1540 | 13.99 |
| 03:37 ET | 2361 | 13.98 |
| 03:39 ET | 850 | 14 |
| 03:42 ET | 720 | 14.04 |
| 03:44 ET | 3482 | 14.05 |
| 03:46 ET | 2154 | 14.05 |
| 03:48 ET | 200 | 14.079 |
| 03:50 ET | 4724 | 14.05 |
| 03:51 ET | 2528 | 14.088 |
| 03:53 ET | 2400 | 14.12 |
| 03:55 ET | 4710 | 14.16 |
| 03:57 ET | 4465 | 14.16 |
| 04:00 ET | 7532 | 14.15 |
Nov 13, 2023
Nov 10, 2023
DJ Pliant Therapeutics Is Maintained at Outperform by RBC Capital, from 2:34PM ET on Friday Nov 10, 2023 by Dow Jones
2:34PM ET on Friday Nov 10, 2023 by Dow Jones
Nov 9, 2023
Pliant Therapeutics Provides Corporate Update and Reports Third Quarter 2023 Financial Results, from 4:05PM ET on Thursday Nov 09, 2023 by Dow Jones
4:05PM ET on Thursday Nov 09, 2023 by Dow Jones*DJ Pliant Therapeutics 3Q Loss/Shr 70c >PLRX, from 4:05PM ET on Thursday Nov 09, 2023 by Dow Jones
4:05PM ET on Thursday Nov 09, 2023 by Dow Jones
Nov 8, 2023
Pliant Therapeutics to Participate in Upcoming Investor Conferences, from 8:00AM ET on Wednesday Nov 08, 2023 by Dow Jones
8:00AM ET on Wednesday Nov 08, 2023 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Pliant Therapeutics Inc | 847.5M | -5.1x | --- |
Avadel Pharmaceuticals PLC | 1.1B | -5.8x | --- |
Microalliance Group Inc | 615.4M | 74.6x | --- |
Tarsus Pharmaceuticals Inc | 525.0M | -4.1x | --- |
Liquidia Corp | 471.9M | -8.2x | --- |
Theravance Biopharma Inc | 530.3M | -10.5x | --- |
Company Information
Pliant Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on discovering and developing therapies for the treatment of fibrosis and related diseases. It focuses in treating fibrosis by inhibiting integrin-mediated activation of transforming growth factor beta (TGF-B). Its lead product candidate, bexotegrast (PLN-74809), is an oral small-molecule, dual-selective inhibitor of avß6 and avB1. Its second product candidate, PLN-1474, is a small-molecule, selective inhibitor of avB1 for treatment of liver fibrosis associated with nonalcoholic steatohepatitis. In addition to its clinical programs, it is developing additional preclinical integrin-based programs targeting muscular dystrophies. It is also developing PLN-101095 an oral, dual inhibitor of αvß8 and αvß1 integrins for the treatment of solid tumors. Its clinical programs also include PLN-101325, an allosteric agonistic monoclonal antibody against α7β1 for treatment of muscular dystrophies.
Contact Information
- Headquarters
- 260 Littlefield Avenue, Suite 150SOUTH SAN FRANCISCO, CA, United States 94080
- Phone
- 650-481-6770
- Fax
- ---
Executives
- Non-Executive Chairman of the Board, Lead Independent Director
- Hoyoung Huh
- President, Chief Executive Officer, Director
- Bernard Coulie
- Chief Financial Officer
- Keith Cummings
- Chief Human Resource Officer
- Lily Cheung
- General Counsel, Corporate Secretary
- Mike Ouimette
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $847.5M |
|---|---|
Revenue (TTM) | $3.5M |
Shares Outstanding | 59.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.13 |
EPS | $-2.78 |
Book Value | $6.40 |
P/E Ratio | -5.1x |
Price/Sales (TTM) | 239.1 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -4,922.65% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
